FAM
BSX icon

Fulcrum Asset Management’s Boston Scientific BSX Stock Holding History

Fulcrum Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,268
Closed -$2.99M – 216
2025
Q1 		$2.99M Sell
38,268
-1,918
-5% -$193K 0.58% 46
2024
Q4 		$2.9M Buy
40,186
+10,191
+34% +$897K 13.56% 3
2024
Q3 		$1.89M Sell
29,995
-817
-3% -$64.4K 4.34% 12
2024
Q2 		$1.93M Buy
+30,812
New +$2.26M 6% 8

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fulcrum Asset Management's BSX Position: Q1 2026 in Review

Fulcrum Asset Management increased its Boston Scientific (BSX) stake by 11% in Q1 2026, buying an estimated $343K and bringing the position to 42,851 shares worth $2.7M. The position accounts for 0.41% of the portfolio, ranked #66.

Fulcrum Asset Management first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.38M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Fulcrum Asset Management held 42,851 shares of Boston Scientific worth $2.7M as of Q1 2026.
  • Fulcrum Asset Management bought 4,292 Boston Scientific shares in Q1 2026, an estimated $343K.
  • Boston Scientific made up 0.41% of Fulcrum Asset Management's portfolio in Q1 2026, its #66 holding.
  • Fulcrum Asset Management first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • Fulcrum Asset Management's Boston Scientific position peaked at $4.38M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fulcrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.